Information for Authors

Dear authors,

Before submitting a manuscript to Biochemistry (Moscow) journal, please read the editorial policy as well as the Instructions for authors. Any deviations from the Instructions may lead to the rejection of the manuscript or a more careful consideration of the manuscripts sent by the authors in the future. We recommend that you familiarize yourself with the samples of manuscripts and follow the format that most closely matches the subject of the manuscript.

A completed Copyright transfer agreement should be submitted together with the manuscript through the Editorial Publishing System (https://publish.sciencejournals.ru/) or via e‑mail (editorial@biochemistrymoscow.com).

Editorial Policy

The following statements are suggesting by author within the submission:

  • the submitted manuscript has not been published previously;
  • the submitted manuscript is not under consideration for publication in another journal;
  • the submitted manuscript was approved by all co‑authors;
  • the submitted manuscript has been approved by all necessary organizations where this work was performed;
  • all authors whose names appear on the submission made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; approved the version to be published; agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

The publisher and editors are not legally liable in the event of material claims from third parties in connection with submitted manuscripts.

Peer-Review

Biochemistry (Moscow) is a peer reviewed journal. We use a single blind peer review format. The average period from submission to first decision is 21 days. The average rejection rate for submitted manuscripts is 78%. All referees’ reports are sent to the Handling Editor responsible to the specific section of the journal topics. The decision is made by the Handling Editor and the Coordinate Editor based on reviewers’ comments.

Any invited reviewer who feels unqualified or unable to review the manuscript due to the conflict of interests should promptly notify the editors and decline the invitation. Reviewers should formulate their statements clearly in a sound and reasoned way so that authors can use reviewer’s arguments to improve the manuscript. Personal criticism of the authors must be avoided. Reviewers should indicate in a review (i) any relevant published work that has not been cited by the authors, (ii) anything that has been reported in previous publications and not given appropriate reference or citation, (ii) any substantial similarity or overlap with any other manuscript (published or unpublished) of which they have personal knowledge.

Ethical Responsibilities

Biochemistry (Moscow) journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) Biochemistry (Moscow) will follow the COPE guidelines on how to deal with potential acts of misconduct. All authors are  requested to include information regarding sources of funding, financial or non‑financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals.

Authors should refrain from misrepresenting research results which could damage the trust in the journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavor. Maintaining integrity of the research and its presentation is helped by following the rules of good scientific practice, which include:

  • The manuscript should not be submitted to more than one journal for simultaneous consideration.
  • The submitted work should be original and should not have been published elsewhere in any form or language (partially or in full), unless the new work concerns an expansion of previous work. (Please provide transparency on the re‑use of material to avoid the concerns about text-recycling (‘self-plagiarism’).
  • A single study should not be split up into several parts to increase the quantity of submissions and submitted to various journals or to one journal over time (i.e. ‘salami-slicing/publishing’).
  • Concurrent or secondary publication is sometimes justifiable, provided certain conditions are met. Examples include: translations or a manuscript that is intended for a different group of readers.
  • Results should be presented clearly, honestly, and without fabrication, falsification or inappropriate data manipulation (including image-based manipulation). Authors should adhere to discipline-specific rules for acquiring, selecting, and processing data.
  • No data, text, or theories by others are presented as if they were the author’s own (‘plagiarism’). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks (to indicate words taken from another source) are used for verbatim copying of material, and permissions secured for material that is copyrighted.
  • Authors should make sure they have permissions for the use of software, questionnaires/(web) surveys and scales in their studies (if appropriate).
  • Research articles and non-research articles (e.g., Opinion, Review, and Commentary articles) must cite appropriate and relevant literature in support of the claims made. Excessive and inappropriate self-citation or coordinated efforts among several authors to collectively self‑cite is strongly discouraged.
  • Authors should avoid untrue statements about an entity (who can be an individual person or a company) or descriptions of their behavior or actions that could potentially be seen as personal attacks or allegations about that person.
  • Research that may be misapplied to pose a threat to public health or national security should be clearly identified in the manuscript (e.g., dual use of research). Examples include creation of harmful consequences of biological agents or toxins, disruption of immunity of vaccines, unusual hazards in the use of chemicals, weaponization of research/technology (amongst others).
  • Authors are strongly advised to ensure the author group, the Corresponding Author, and the order of authors are all correct at submission. Adding and/or deleting authors during the revision stages is generally not permitted, but in some cases may be warranted. Reasons for changes in authorship should be explained in detail. Please note that changes to authorship cannot be made after acceptance of a manuscript.
  • Upon request authors should be prepared to send relevant documentation or data in order to verify the validity of the results presented. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential or proprietary data is excluded.